The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
Epilepsy encompasses a heterogeneous group of neurological syndromes which are characterized by recurrent seizures affecting over 60 million people worldwide. Current anti-epileptic drugs (AEDs) are mainly designed to target ion channels and/or GABA or glutamate receptors. Despite recent advances in...
Saved in:
Main Authors: | Mariana Alves (Author), Edward Beamer (Author), Tobias Engel (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy
by: Engel T, et al.
Published: (2021) -
Differential Expression of the Metabotropic P2Y Receptor Family in the Cortex Following Status Epilepticus and Neuroprotection via P2Y1 Antagonism in Mice
by: Mariana Alves, et al.
Published: (2020) -
Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs
by: Carolina eMuguruza, et al.
Published: (2016) -
Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
by: Qihang Kong, et al.
Published: (2021) -
Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy
by: Ágatha Oliveira-Giacomelli, et al.
Published: (2018)